Differentiating Polyarteritis nodosa from other diseases: Difference between revisions
Sargun Walia (talk | contribs) |
Sargun Walia (talk | contribs) No edit summary |
||
Line 21: | Line 21: | ||
*[[Mycotic aneurysm]] | *[[Mycotic aneurysm]] | ||
*[[Atherosclerosis]] | *[[Atherosclerosis]] | ||
<span style="font-size:85%">'''Abbreviations:''' | |||
ABG= [[Arterial blood gas]], ANA= [[Antinuclear antibody]], ANP= [[Atrial natriuretic peptide]], ASO= [[Antistreptolysin O|Antistreptolysin O antibody]], BNP= [[Brain natriuretic peptide]], CBC= [[Complete blood count]], COPD= [[Chronic obstructive pulmonary disease]], CRP= [[C-reactive protein]], CT= [[Computed tomography]], CXR= [[Chest X-ray]], DVT= [[Deep vein thrombosis]], ESR= [[Erythrocyte sedimentation rate]], HRCT= [[High Resolution CT]], IgE= [[Immunoglobulin E]], LDH= [[Lactate dehydrogenase]], PCWP= [[Pulmonary capillary wedge pressure]], PCR= [[Polymerase chain reaction]], PFT= [[Pulmonary function test]].</span> | |||
<small> | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | |||
! colspan="3" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Diseases | |||
| colspan="8" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestations''' | |||
! colspan="9" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Para-clinical findings | |||
| colspan="1" rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Gold standard''' | |||
! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Additional findings | |||
|- | |||
| colspan="5" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Symptoms''' | |||
! colspan="3" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" | Physical examination | |||
|- | |||
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Lab Findings | |||
! colspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging | |||
! rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Histopathology | |||
|- | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Headache | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Fever | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Arthralgia | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Claudication | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Bruit | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |HTN | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Focal neurological disorder | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Biomarker | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CBC | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |ESR | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |CT scan | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Angiography | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Ultrasound/ Echocardiography | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Other | |||
|- | |||
! rowspan="18" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Medium-Vessel Vasculitis | |||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Polyarteritis nodosa]]<ref name="pmid25770638">{{cite journal| author=Howard T, Ahmad K, Swanson JA, Misra S| title=Polyarteritis nodosa. | journal=Tech Vasc Interv Radiol | year= 2014 | volume= 17 | issue= 4 | pages= 247-51 | pmid=25770638 | doi=10.1053/j.tvir.2014.11.005 | pmc=4363102 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25770638 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[LAMP2|LAMP-2 protein autoantibodies]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Normochromic anemia]], [[Thrombocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ [[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], | |||
↑ [[ALT]] or [[AST]], [[Proteinuria]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Focal regions of [[infarction]] or [[hemorrhage]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Multiple [[Aneurysm|microaneurysms]], [[Hemorrhage]] due to focal [[rupture]], [[Occlusion]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aneurysms]] and [[renal]] [[arteriovenous fistula]] in [[Doppler sonography|color Doppler sonography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Necrotizing]] [[inflammatory]] lesions | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Angiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Sudden [[weight loss]], [[Abdominal pain]] | |||
|- | |||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis B virus]]-associated [[polyarteritis nodosa]]<ref name="pmid25755502">{{cite journal |vauthors=Sharma A, Sharma K |title=Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis |journal=J Clin Exp Hepatol |volume=3 |issue=3 |pages=204–12 |date=September 2013 |pmid=25755502 |pmc=4216827 |doi=10.1016/j.jceh.2013.06.001 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hepatitis B surface antigen|HBsAg]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]], [[Normochromic anemia]], [[Thrombocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ [[ALT]] or [[AST]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Focal regions of [[infarction]] or [[hemorrhage]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aneurysms|Microaneurysms]] in [[mesenteric artery]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Aneurysms]] and [[renal]] [[arteriovenous fistula]] in [[Doppler sonography|color Doppler sonography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Necrotizing]] [[inflammatory]] lesions | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Angiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Peripheral neuropathy]], [[Livedo reticularis]] | |||
|- | |||
! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Kawasaki disease]]<ref name="pmid21447126">{{cite journal| author=Takahashi K, Oharaseki T, Yokouchi Y| title=Pathogenesis of Kawasaki disease. | journal=Clin Exp Immunol | year= 2011 | volume= 164 Suppl 1 | issue= | pages= 20-2 | pmid=21447126 | doi=10.1111/j.1365-2249.2011.04361.x | pmc=3095860 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21447126 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[NT-proBNP]], [[Meprin A]], [[Filamin A interacting protein 1 like|Filamin C]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Normochromic anemia]], ↑[[WBC]] with a [[left shift]], [[Thrombocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acute phase reactant|Acute-phase reactants]], ↓[[Cholesterol]], ↓[[HDL]], ↓[[Apolipoprotein A1|ApolipoA]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Coronary artery]] [[Calcification|calcifications]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Coronary artery aneurysm|Coronary artery aneurysms]], [[Coronary artery stenosis|stenosis]] or [[Coronary artery anomaly|occlusion]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Coronary artery anomaly]] in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Electron beam tomography|Electron beam CT (EBCT)]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Acute destruction of the [[Tunica media|media]] by [[neutrophils]], with loss of [[elastic fibers]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |History and [[physical examination]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Diarrhea]], [[Vomiting]] | |||
|- | |||
! rowspan="10" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Infectious disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Parvovirus B19 infection]]<ref name="pmid12097253">{{cite journal| author=Heegaard ED, Brown KE| title=Human parvovirus B19. | journal=Clin Microbiol Rev | year= 2002 | volume= 15 | issue= 3 | pages= 485-505 | pmid=12097253 | doi= | pmc=118081 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12097253 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Parvovirus B19|B19]] [[DNA]], ↓[[Reticulocyte count]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |anti–[[parvovirus B19]] [[IgM]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hydrops]] in fetal [[ultrasonography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Parvovirus B19|B19]] [[DNA]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Purpura|Purpuric rash]], [[Erythema multiforme]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Scarlet fever]]<ref name="pmid29081840">{{cite journal| author=Basetti S, Hodgson J, Rawson TM, Majeed A| title=Scarlet fever: a guide for general practitioners. | journal=London J Prim Care (Abingdon) | year= 2017 | volume= 9 | issue= 5 | pages= 77-79 | pmid=29081840 | doi=10.1080/17571472.2017.1365677 | pmc=5649319 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29081840 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antistreptococcal antibodies|Antistreptolysin-O (ASO) titers]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[CRP]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Thickened [[pulmonary]] markings if [[pneumonia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Sparse [[Neutropenia|neutrophilic]] [[Perivascular cell|perivascular infiltrate]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |History and [[physical examination]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Sand-paper rashes, [[Sore throat]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Toxic shock syndrome]]<ref name="pmid22180682">{{cite journal| author=Vostral SL| title=Rely and Toxic Shock Syndrome: a technological health crisis. | journal=Yale J Biol Med | year= 2011 | volume= 84 | issue= 4 | pages= 447-59 | pmid=22180682 | doi= | pmc=3238331 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22180682 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Procalcitonin]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]] with [[left shift]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Myoglobinuria]], [[Pyuria|Sterile pyuria]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acute respiratory distress syndrome]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Necrosis|Necrolysis]] of [[keratinocytes]] in [[epidermis]], Perivascular [[lymphocytic]] infiltrate | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical criteria | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Peeling or [[rashes]], Organ dysfunction | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Mononucleosis]]<ref name="pmid25774295">{{cite journal| author=Balfour HH, Dunmire SK, Hogquist KA| title=Infectious mononucleosis. | journal=Clin Transl Immunology | year= 2015 | volume= 4 | issue= 2 | pages= e33 | pmid=25774295 | doi=10.1038/cti.2015.1 | pmc=4346501 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25774295 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Epstein Barr virus|EBV]] [[DNA]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Atypical lymphocyte]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Heterophile antibody test|Heterophile antibodies]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[CNS Disease|CNS involvement]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Splenomegaly]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Encephalitis]] in [[MRI]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lymphoproliferative response]] in [[oropharynx]], [[Lymphocytic|Lymphocytic infiltration]] in [[spleen]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Heterophile antibody test]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Splenomegaly]], [[Palatal]] [[petechiae]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Leptospirosis]]<ref name="pmid11292640">{{cite journal |vauthors=Levett PN |title=Leptospirosis |journal=Clin. Microbiol. Rev. |volume=14 |issue=2 |pages=296–326 |date=April 2001 |pmid=11292640 |pmc=88975 |doi=10.1128/CMR.14.2.296-326.2001 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Interleukin 6|IL-6]], [[IL-8]] and [[IL-10]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Creatinine|Cr]] or [[Blood urea nitrogen|BUN]], | |||
↑[[ALT]] or [[AST]], [[Proteinuria]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | Diffuse [[alveolar]] [[hemorrhage]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Toxin]]-mediated break down of [[endothelial cell]] membranes of [[capillaries]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Culture and the [[Agglutination|microscopic agglutination test]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Red eyes]], [[Skin rash]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Lyme disease|Lyme Disease]]<ref name="pmid23319969">{{cite journal| author=Biesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T| title=Lyme disease: review. | journal=Arch Med Sci | year= 2012 | volume= 8 | issue= 6 | pages= 978-82 | pmid=23319969 | doi=10.5114/aoms.2012.30948 | pmc=3542482 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23319969 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[CXCL9|CXCL9 (MIG)]], [[CXCL10|CXCL10 (IP-10)]] and [[CCL19|CCL19 (MIP3B)]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukopenia]], [[Thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Microscopic hematuria]], [[Proteinuria]], ↑[[ALT]] or [[AST]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Punctate lesions in periventricular [[white matter]] in [[brain]] [[SPECT]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Acrodermatitis chronica atrophicans]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Serological testing|Serologic '''tests''']] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Erythema migrans]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Measles]]<ref name="pmid22510638">{{cite journal| author=White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM| title=Measles, mumps, and rubella. | journal=Clin Obstet Gynecol | year= 2012 | volume= 55 | issue= 2 | pages= 550-9 | pmid=22510638 | doi=10.1097/GRF.0b013e31824df256 | pmc=3334858 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22510638 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Measles]] [[Immunoglobulin M|IgM]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukopenia]], [[Lymphocytosis]], [[Thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[ALT]] or [[AST]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pneumonia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Chest X-ray|CXR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Spongiosis and vesiculation in the [[epidermis]] with scattered dyskeratotic [[keratinocytes]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[PCR]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Rash|Generalized rash]], [[Cough]], [[Coryza]], or [[Conjunctivitis]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Rocky Mountain Spotted Fever]]<ref name="pmid2504480">{{cite journal| author=Walker DH| title=Rocky Mountain spotted fever: a disease in need of microbiological concern. | journal=Clin Microbiol Rev | year= 1989 | volume= 2 | issue= 3 | pages= 227-40 | pmid=2504480 | doi= | pmc=358117 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2504480 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |''[[Rickettsia rickettsii infection|R rickettsii]]'' [[serology]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thrombocytopenia]], [[Anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[ALT]] or [[AST]], [[Hyponatremia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Infarction]], [[edema]], and [[meningeal]] enhancement | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Myocardial]] or conduction abnormalities in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Immunofluorescent]] or [[immunoperoxidase]] staining of ''[[Rickettsia rickettsii infection|R rickettsii]]'' | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Clinical criteria and [[tick]] exposure | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Rash on the [[Palms of the hands|palms]] and [[soles]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Staphylococcal scalded skin syndrome|Staphylococcal Scalded Skin Syndrome]]<ref name="pmid27651848">{{cite journal| author=Mishra AK, Yadav P, Mishra A| title=A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates. | journal=Open Microbiol J | year= 2016 | volume= 10 | issue= | pages= 150-9 | pmid=27651848 | doi=10.2174/1874285801610010150 | pmc=5012080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27651848 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Anti exfoliatin and [[Alpha toxin|anti alpha-toxin antibodies]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]] with [[left shift]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Blood culture]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Pneumonia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Epidermal bullosa simplex|Intraepidermal blister]], dense superficial perivascular lymphohistiocytic infiltrate | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Blood culture]] and clinical findings | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Erythroderma|'''Widespread''' skin erythema]], [[Blisters|fluid-filled '''blisters''']] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Toxic Epidermal Necrolysis]]<ref name="pmid27239294">{{cite journal| author=Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E et al.| title=Toxic epidermal necrolysis. | journal=F1000Res | year= 2016 | volume= 5 | issue= | pages= | pmid=27239294 | doi=10.12688/f1000research.7574.1 | pmc=4879934 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27239294 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[MicroRNA|MicroRNA-124]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Normocytic normochromic anemia|Normochromic normocytic anemia]], [[Eosinophilia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Fluid loss]] and [[electrolyte abnormalities]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Tracheobronchial]] [[inflammation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Necrotic]] [[keratinocytes]] with full-thickness [[epithelial]] [[necrosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Histopathology]] and clinical findings | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Erythematous rash|Erythematous macular rash]] with [[purpuric]] centers | |||
|- | |||
! rowspan="3" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cardiovascular disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Atrial Myxoma]]<ref name="pmid8407260">{{cite journal |vauthors=MacGowan SW, Sidhu P, Aherne T, Luke D, Wood AE, Neligan MC, McGovern E |title=Atrial myxoma: national incidence, diagnosis and surgical management |journal=Ir J Med Sci |volume=162 |issue=6 |pages=223–6 |date=June 1993 |pmid=8407260 |doi= |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Calretinin]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Mild [[anemia]], [[Leukocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑[[Interleukin 6|IL-6]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Atrial]] filling defect larger than a [[thrombus]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Tumor]] location, size, attachment, and mobility in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Size, shape, and surface characteristics in [[MRI]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lipid|Lipidic]] cells embedded in a [[vascular]] myxoid stroma | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Dyspnea on exertion]], [[Syncope]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cholesterol Embolism]]<ref name="pmid21886725">{{cite journal| author=Avci G, Akoz T, Gul AE| title=Cutaneous cholesterol embolization. | journal=J Dermatol Case Rep | year= 2009 | volume= 3 | issue= 2 | pages= 27-9 | pmid=21886725 | doi=10.3315/jdcr.2009.1031 | pmc=3157794 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21886725 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Interleukin 5|IL-5]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Eosinophilia]], [[Leukocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Eosinophiluria]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thoracic aorta|Thoracic]] and [[Abdominal aorta|abdominal aortic]] sources of [[embolism]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Atheroembolism]] in [[abdominal aorta]] and the [[lower extremity]] [[arteries]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Excluding an [[intracardiac]] source of [[embolism]] with [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Birefringent]] crystals or biconvex needle-shaped ghostly clefts within the [[arterial]] [[lumen]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Angiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Livedo reticularis]], | |||
[ | [[Ischemic|Ischemic patches]] | ||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Segmental arteries|Segmental arterial]] mediolysis<ref name="Chao2009">{{cite journal|last1=Chao|first1=Christine|title=Segmental Arterial Mediolysis|journal=Seminars in Interventional Radiology|volume=26|issue=03|year=2009|pages=224–232|issn=0739-9529|doi=10.1055/s-0029-1225666}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Leukocytosis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Visceral]] artery [[aneurysm]] in [[CT angiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Alternating [[aneurysms]] and [[stenoses]] (beading) | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Retroperitoneal hematoma]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Disruption of the [[smooth muscle]] in the [[Tunica media|media]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Angiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Hematuria]], [[Ischemic colitis]] | |||
|- | |||
! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Systemic disease]] | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Antiphospholipid syndrome|Antiphospholipid Syndrome]]<ref name="pmid26637701">{{cite journal| author=Chaturvedi S, McCrae KR| title=The antiphospholipid syndrome: still an enigma. | journal=Hematology Am Soc Hematol Educ Program | year= 2015 | volume= 2015 | issue= | pages= 53-60 | pmid=26637701 | doi=10.1182/asheducation-2015.1.53 | pmc=4877624 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26637701 }}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antiphospholipid antibodies]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thrombocytopenia]], [[Hemolytic anemia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lupus anticoagulant|Lupus anticoagulant (LA)]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Stroke]], | |||
[[Pulmonary embolism]], [[Budd-Chiari syndrome]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Thrombus]] in major [[vessels]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Valve thickening, vegetations, or insufficiency in [[echocardiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Noninflammatory bland [[thrombosis]] without perivascular [[inflammation]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Hx of [[thrombosis]] and [[antiphospholipid antibodies]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Miscarriage]], [[Pulmonary hypertension]] | |||
|- | |||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Juvenile Idiopathic Arthritis]]<ref name="pmid22753788">{{cite journal |vauthors=Espinosa M, Gottlieb BS |title=Juvenile idiopathic arthritis |journal=Pediatr Rev |volume=33 |issue=7 |pages=303–13 |date=July 2012 |pmid=22753788 |doi=10.1542/pir.33-7-303 |url=}}</ref> | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Rheumatoid factor|Rheumatoid factor (RF)]], [[S100A12]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Lymphocytosis]], [[Thrombocytopenia]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑ | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Myeloid-related proteins 8/14 (MRP8/14) | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Synovial]] [[hypertrophy]], Joint effusions | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Cerebral vasculitis]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Inflamed [[synovium]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Bone scan|Bone scanning]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Vascular congestion]], [[Extravasation|RBC extravasation]], Venular lumen occlusion | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Conventional [[radiography]] | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Rash|Evanescent rash]], [[Dactylitis]] | |||
|- | |||
|} | |||
</small> | |||
==References== | |||
{{Reflist|2}} | |||
[[Category: Medicine]] | |||
[[Category: Up-To-Date]] | |||
[[Category: Primary care]] | |||
[[Category: Rheumatology]] | |||
{{WH}} | |||
{{WS}} |
Revision as of 14:14, 9 May 2018
Polyarteritis nodosa Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Differentiating Polyarteritis nodosa from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating Polyarteritis nodosa from other diseases |
FDA on Differentiating Polyarteritis nodosa from other diseases |
CDC on Differentiating Polyarteritis nodosa from other diseases |
Differentiating Polyarteritis nodosa from other diseases in the news |
Blogs on Differentiating Polyarteritis nodosa from other diseases |
Risk calculators and risk factors for Differentiating Polyarteritis nodosa from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2] Cafer Zorkun, M.D., Ph.D. [3]; Haritha Machavarapu, M.B.B.S.
Overview
PAN must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Differentiating Polyarteritis Nodosa from other Diseases
- Microscopic polyangitis has clinical manifestations similar to PAN, but is characterized by presence of rapidly progressive glomerulonephritis and lung involvement unlike PAN.[1]
- Churg Strauss disease is characterized by hypereosinophilia and vasculitis like PAN in individuals with asthma and allergic nephritis.
- Henoch-Schonlein purpura
- Vasculitis secondary to connective tissue disorder
- Cryoglobulinemic vasculitis
- Wegner's Granulomatosis
- Giant cell arteritis
- Infective endocarditis
- Mycotic aneurysm
- Atherosclerosis
Abbreviations: ABG= Arterial blood gas, ANA= Antinuclear antibody, ANP= Atrial natriuretic peptide, ASO= Antistreptolysin O antibody, BNP= Brain natriuretic peptide, CBC= Complete blood count, COPD= Chronic obstructive pulmonary disease, CRP= C-reactive protein, CT= Computed tomography, CXR= Chest X-ray, DVT= Deep vein thrombosis, ESR= Erythrocyte sedimentation rate, HRCT= High Resolution CT, IgE= Immunoglobulin E, LDH= Lactate dehydrogenase, PCWP= Pulmonary capillary wedge pressure, PCR= Polymerase chain reaction, PFT= Pulmonary function test.
References
- ↑ Lhote F, Cohen P, Guillevin L (1998). "Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome". Lupus. 7 (4): 238–58. PMID 9643314.
- ↑ Howard T, Ahmad K, Swanson JA, Misra S (2014). "Polyarteritis nodosa". Tech Vasc Interv Radiol. 17 (4): 247–51. doi:10.1053/j.tvir.2014.11.005. PMC 4363102. PMID 25770638.
- ↑ Sharma A, Sharma K (September 2013). "Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis". J Clin Exp Hepatol. 3 (3): 204–12. doi:10.1016/j.jceh.2013.06.001. PMC 4216827. PMID 25755502.
- ↑ Takahashi K, Oharaseki T, Yokouchi Y (2011). "Pathogenesis of Kawasaki disease". Clin Exp Immunol. 164 Suppl 1: 20–2. doi:10.1111/j.1365-2249.2011.04361.x. PMC 3095860. PMID 21447126.
- ↑ Heegaard ED, Brown KE (2002). "Human parvovirus B19". Clin Microbiol Rev. 15 (3): 485–505. PMC 118081. PMID 12097253.
- ↑ Basetti S, Hodgson J, Rawson TM, Majeed A (2017). "Scarlet fever: a guide for general practitioners". London J Prim Care (Abingdon). 9 (5): 77–79. doi:10.1080/17571472.2017.1365677. PMC 5649319. PMID 29081840.
- ↑ Vostral SL (2011). "Rely and Toxic Shock Syndrome: a technological health crisis". Yale J Biol Med. 84 (4): 447–59. PMC 3238331. PMID 22180682.
- ↑ Balfour HH, Dunmire SK, Hogquist KA (2015). "Infectious mononucleosis". Clin Transl Immunology. 4 (2): e33. doi:10.1038/cti.2015.1. PMC 4346501. PMID 25774295.
- ↑ Levett PN (April 2001). "Leptospirosis". Clin. Microbiol. Rev. 14 (2): 296–326. doi:10.1128/CMR.14.2.296-326.2001. PMC 88975. PMID 11292640.
- ↑ Biesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T (2012). "Lyme disease: review". Arch Med Sci. 8 (6): 978–82. doi:10.5114/aoms.2012.30948. PMC 3542482. PMID 23319969.
- ↑ White SJ, Boldt KL, Holditch SJ, Poland GA, Jacobson RM (2012). "Measles, mumps, and rubella". Clin Obstet Gynecol. 55 (2): 550–9. doi:10.1097/GRF.0b013e31824df256. PMC 3334858. PMID 22510638.
- ↑ Walker DH (1989). "Rocky Mountain spotted fever: a disease in need of microbiological concern". Clin Microbiol Rev. 2 (3): 227–40. PMC 358117. PMID 2504480.
- ↑ Mishra AK, Yadav P, Mishra A (2016). "A Systemic Review on Staphylococcal Scalded Skin Syndrome (SSSS): A Rare and Critical Disease of Neonates". Open Microbiol J. 10: 150–9. doi:10.2174/1874285801610010150. PMC 5012080. PMID 27651848.
- ↑ Hoetzenecker W, Mehra T, Saulite I, Glatz M, Schmid-Grendelmeier P, Guenova E; et al. (2016). "Toxic epidermal necrolysis". F1000Res. 5. doi:10.12688/f1000research.7574.1. PMC 4879934. PMID 27239294.
- ↑ MacGowan SW, Sidhu P, Aherne T, Luke D, Wood AE, Neligan MC, McGovern E (June 1993). "Atrial myxoma: national incidence, diagnosis and surgical management". Ir J Med Sci. 162 (6): 223–6. PMID 8407260.
- ↑ Avci G, Akoz T, Gul AE (2009). "Cutaneous cholesterol embolization". J Dermatol Case Rep. 3 (2): 27–9. doi:10.3315/jdcr.2009.1031. PMC 3157794. PMID 21886725.
- ↑ Chao, Christine (2009). "Segmental Arterial Mediolysis". Seminars in Interventional Radiology. 26 (03): 224–232. doi:10.1055/s-0029-1225666. ISSN 0739-9529.
- ↑ Chaturvedi S, McCrae KR (2015). "The antiphospholipid syndrome: still an enigma". Hematology Am Soc Hematol Educ Program. 2015: 53–60. doi:10.1182/asheducation-2015.1.53. PMC 4877624. PMID 26637701.
- ↑ Espinosa M, Gottlieb BS (July 2012). "Juvenile idiopathic arthritis". Pediatr Rev. 33 (7): 303–13. doi:10.1542/pir.33-7-303. PMID 22753788.